TACR1 and glioblastoma: Hence, to determine the SP/NK1R signaling effect in U87 glioblastoma cells, we assessed the intracellular ROS levels in response to SP (100 and 400 nM) alone or in combination with aprepitant (15 μM) by DCFH-DA assay.